501
|
|
|
C-C motif chemokine ligand 5 |
D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP |
Asthma, Autoimmune hepatitis, Biliary cirrhosis, Atopic dermatitis, Diabetes mellitus type 1, Glomerulonephritis, Hepatitis b, Hepatitis c, Alcoholic hepatitis, Hyperoxaluria, Liver cirrhosis, Mesothelioma, Pancreatitis, Biliary cholangitis, Pulmonary fibrosis |
502
|
|
|
C-C motif chemokine ligand 7 |
FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7 |
|
503
|
|
|
C-C motif chemokine ligand 8 |
HC14, MCP-2, MCP2, SCYA10, SCYA8 |
|
504
|
|
|
CCM2 scaffold protein |
C7orf22, OSM, PP10187 |
Cavernous malformations of cns, Cerebral cavernous malformation, Colorectal cancer, Congenital cerebral aneurysm, Congenital malformation of cerebral vessels, Coronary artery disease, Vascular dementia, Developmental venous anomaly, Cerebral cavernous malformations, Myocardial infarction, Diabetes mellitus type 2, Vasculitis |
505
|
|
|
CCM2 like scaffold protein |
C20orf160, dJ310O13.5 |
|
506
|
|
|
Cellular communication network factor 1 |
CYR61, GIG1, IGFBP10 |
|
507
|
|
|
Cellular communication network factor 2 |
CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2, SEMDLSL |
Aortic valve disease, Rheumatoid arthritis, Epithelial ovarian carcinoma, Cholelithiasis, Congestive heart failure, Contact dermatitis, Gestational diabetes, Diffuse cutaneous systemic sclerosis, Focal glomerulosclerosis, Heart failure, Hepatitis b, Hypertension, Female infertility, Crest syndrome, Liver cirrhosis, Lung disease, Lung neoplasms, Pulmonary fibrosis, Rheumatic aortic regurgitation, Scleroderma, Spondyloepimetaphyseal dysplasia, Systemic sclerosisView all (7 more) |
508
|
|
|
Cellular communication network factor 3 |
IBP-9, IGFBP-9, IGFBP9, NOV, NOVh |
|
509
|
|
|
Cellular communication network factor 4 |
WISP1, WISP1-OT1, WISP1-UT1, WISP1c, WISP1i, WISP1tc |
|
510
|
|
|
Cellular communication network factor 6 |
LIBC, PPAC, PPD, PPRD, WISP-3, WISP3 |
|